# Early Clonal Dynamics During Venetoclax Treatment for Relapsed or Refractory Chronic Lymphocytic Leukemia (CLL)

> clinical trial · VERIFIED · 2026-08-12

Status: RECRUITING · Sponsor: National Heart, Lung, and Blood Institute (NHLBI) · Condition: Chronic Lymphocytic Leukemia

- Company: National Heart, Lung, and Blood Institute (NHLBI)
- Sector: oncology
- Primary source: https://clinicaltrials.gov/study/NCT03986034

---
Source: MedFuel Intel news monitor. Verification tier: VERIFIED. Informational only, not investment advice. Corrections: media@medfuelinc.com.